Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 6 Nov 2006):

Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.

Full Abstract

Serotonergic neurotransmission has been implicated in memory impairment. It is unclear however if memory performance is mediated through general 5-HT availability, through specific 5-HT receptors or both. The aim of the present study was to assess the contribution of 5-HT reuptake inhibition and specific blockade of 5-HT(1A) and 5-HT(2A) receptors to memory impairment.The study was conducted according to a randomized, double-blind, placebo-controlled, four-way cross-over design including 16 healthy volunteers. The treatment consisted of oral administration of escitalopram 20 mg + placebo, escitalopram 20 mg + ketanserin 50 mg, escitalopram 20 mg + pindolol 10 mg and placebo on 4 separate days with a washout period of minimum 7 days. Different memory tasks were performed including verbal memory, spatial working memory and reversal learning. Escitalopram showed an impairing effect on immediate verbal recall which nearly reached statistical significance. No effects of escitalopram were found on other types of memory. In combination with pindolol, immediate verbal recall was significantly impaired. Escitalopram in combination with ketanserin impaired spatial working memory significantly. No effects were found on reversal learning.Selective impairment of immediate verbal recall after a 5-HT(1A) partial agonist and selective impairment of spatial working memory performance after 5-HT(2A) receptor antagonist, both in combination with a selective serotonergic reuptake inhibitor (escitalopram), suggests that 5-HT(1A) and 5-HT(2A) receptors are distinctly involved in verbal and spatial memory.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Wingen, M (M); Kuypers, K P C (KP); Ramaekers, J G (JG);

Affiliation: Experimental Psychopharmacology Unit, Faculty of Psychology, Brain & Behaviour Institute, Maastricht University, The Netherlands. m.wingen(-atsign-)psychology.unimaas.nl

Journal and publication information

Publication Type: Journal Article; Randomized Controlled Trial

Journal: Journal of psychopharmacology (Oxford, England) (J Psychopharmacol), published in United States. (Language: eng)

Reference: 2007-Jul; vol 21 (issue 5) : pp 477-85

Dates: Created 2007/07/31; Completed 2007/10/04;

PMID: 17092965, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Receptor, Serotonin, 5-HT2A (0) ; Serotonin Antagonists (0) ; Serotonin Uptake Inhibitors (0) ; Receptor, Serotonin, 5-HT1A (112692-38-3) ; Pindolol (13523-86-9) ; Serotonin (50-67-9) ; Citalopram (59729-33-8) ; Ketanserin (74050-98-9)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1992
8/30/2006
Higher Relevance Score (15)
Lower Relevance Score (13)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index